ZUMZ : Summary for Zumiez Inc. - Yahoo Finance

U.S. Markets open in 1 hr 32 mins

Zumiez Inc. (ZUMZ)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.25+0.50 (+2.82%)
At close: 4:00PM EDT
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close17.75
Bid16.70 x 100
Ask0.00 x
Day's Range17.60 - 18.60
52 Week Range13.50 - 26.55
Avg. Volume454,254
Market Cap455.22M
PE Ratio (TTM)17.55
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zumiez, Inc. :ZUMZ-US: Earnings Analysis: Q4, 2017 By the Numbers : March 24, 2017
    Capital Cube6 days ago

    Zumiez, Inc. :ZUMZ-US: Earnings Analysis: Q4, 2017 By the Numbers : March 24, 2017

    Categories: Yahoo Finance Get free summary analysis Zumiez, Inc. reports financial results for the quarter ended January 31, 2017. We analyze the earnings along side the following peers of Zumiez, Inc. – Tailored Brands, Inc., Buckle, Inc., Tilly’s, Inc. Class A, Express, Inc., Urban Outfitters, Inc., Francesca’s Holdings Corporation, Destination XL Group, Inc., Abercrombie & Fitch Co. Class ... Read more (Read more...)

  • Zacks17 days ago

    Company News for March 13, 2017

    Companies In The News are: ULTA,ZUMZ,HIBB,MTN

  • Barrons.com19 days ago

    [$$] Charting the Market

    H&R Block As the big day approaches, the tax-prep giant reported a narrower-than-expected quarterly loss and seemed to be gaining share in a declining market. American Airlines Group The air carrier lowered its quarterly unit-revenue guidance, a key measure of activity. Concert Pharmaceuticals Vertex Pharmaceuticals will buy the company’s cystic fibrosis treatment for $160 million in cash for development rights, with further payouts possible.